September 2026
The U.S. DNA nanotechnology market size is accounted to hit around USD 18.03 billion by 2035 increasing from USD 2.52 billion in 2026, with a CAGR of 24.53%.
September 2026
The global DNA nanotechnology market size was exhibited at USD 8.60 billion in 2026 and is predicted to surpass around USD 60.27 billion by 2035, with a solid CAGR of 24.24%.
September 2026
The U.S. targeted DNA RNA sequencing market size is accounted to hit around USD 27.72 billion by 2035 increasing from USD 5.73 billion in 2026, with a CAGR of 19.17%.
September 2026
The U.S. DNA synthesis market generated USD 2.30 billion in 2026, with prominent U.S. DNA synthesis market companies including LGC Biosearch Technologie, Bioneer Corporation, Thermo Fisher Scientific, Inc.
May 2026
The U.S. plasmid DNA manufacturing market size was exhibited at USD 810 million in 2025 and is projected to hit USD 4,003 million by 2035, at a CAGR of 18.41%.
September 2026
The US viral vectors and plasmid DNA manufacturing market size is valued at USD 3.30 billion in 2026 and is predicted to hit USD 11.69 billion by 2035, with a CAGR of 15.20%.
September 2026
The U.S. nitrogenous fertilizer market size surpassed USD 12,092.30 million in 2026 and is predicted to be worth around USD 14,902.41 million by 2035 with a CAGR of 2.39%.
September 2026
The global recombinant DNA technology market size was valued at USD 973.64 billion in 2026 and is expected to hit around USD 1,719.89 billion by 2035, at a CAGR of 6.53%.
September 2026
The U.S. corporate wellness market size is expected to increase to USD 44.24 billion by 2035 from USD 24.85 billion in 2025, with a CAGR of 6.59%.
September 2026
The global U.S. oral care market size is calculated at USD 11.11 billion in 2026 and is projected to hit around USD 16.60 billion by 2035 with a CAGR of 4.57%.
September 2026
The U.S. digital therapeutics market size is exhibited at USD 4.56 billion in 2026 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The circulating tumor DNA (ctDNA) market size was USD 9.14 billion in 2026, with leading circulating tumor DNA (ctDNA) market players including Guardant Health, Roche Diagnostics, Illumina.
September 2026
The U.S. pharmaceutical market was valued at USD 552.72 billion in 2026, with leading companies including Johnson & Johnson, Pfizer, Merck & Co., AbbVie, Bristol Myers Squibb, Eli Lilly.
September 2026
The U.S. pharmaceutical CDMO market size was calculated at USD 46.55 billion in 2026 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The U.S. hospital emergency department market is estimated to hit around USD 307.63 billion by 2035 increasing from USD 190.70 billion in 2026, with a CAGR of 5.44%.
September 2026
The global nanotechnology market size is evaluated at USD 11.69 billion in 2026 and is predicted to hit around USD 139.37 billion by 2035 with a CAGR of 31.85%.
September 2026
The U.S. pharmacy benefit management market was valued at USD 504.08 billion in 2026, with leading companies including Cigna Group, CVS Health, MedImpact.
September 2026
The global DNA diagnostics market size is accounted at USD 12.14 billion in 2026 and is projected to hit around USD 17.78 billion by 2035 with a CAGR of 4.32%.
September 2026
The U.S. AI materials product optimization market expands with innovations in computational modeling, automated labs, and AI-driven material design.
September 2026
The U.S. complex and chronic condition management market size is valued at USD 7.47 billion in 2026 and is expected to reach over USD 18.33 billion by 2035, with a registered CAGR of 11.18%.
September 2026
The global targeted DNA RNA sequencing market size is estimated to hit around USD 80.78 billion by 2035, increasing from USD 17.06 billion in 2026, with a CAGR of 18.92%.
September 2026
The US dental services market size is calculated at USD 185.39 billion in 2026 and is expected to surpass USD 281.20 billion by 2035, growing at a CAGR of 4.86%.
September 2026
The U.S. acute hospital care market size is expected to attain around USD 2.57 trillion by 2035 from USD 1.45 trillion in 2026 with a notable CAGR of 6.65%.
September 2026
The U.S. investment banking and asset management market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
September 2026
The U.S. medical oxygen concentrators market size is estimated to Surge around USD 690 million by 2035 increasing from USD 400 million in 2026, with a CAGR of 6.15%.
September 2026
The plasmid DNA manufacturing market size was estimated at USD 3.20 billion in 2026 and is expected to hit around USD 12.45 billion by 2035, growing at a CAGR of 16.78%.
September 2026
The U.S. behavioral health market is projected to grow from USD 100.9 billion in 2026 to USD 174.78 billion by 2035, registering a CAGR of 6.31%.
September 2026
The U.S. concierge medicine market generated USD 6.99 billion in 2026, with prominent U.S. concierge medicine market companies including Priority Physicians, Inc., Castle Connolly Private Health Partners, PartnerMD, Concierge Consultants and CardiologyÂ
September 2026
The aerospace nanotechnology market size was valued at USD 5.51 billion in 2024 and is expected to hit around USD 8.10 billion by 2034 with a CAGR of 3.93%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com